Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG.

J Clin Oncol. 2009 Mar 1;27(7):1007-13. doi: 10.1200/JCO.2007.13.8925. Epub 2009 Jan 26. Erratum in: J Clin Oncol. 2014 Jun 10;32(17):1862-3.

2.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, van Dalen EC.

Cochrane Database Syst Rev. 2015 Oct 5;(10):CD006301. doi: 10.1002/14651858.CD006301.pub4. Review.

PMID:
26436598
3.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301. doi: 10.1002/14651858.CD006301.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD006301.

PMID:
23970444
4.

Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.

Peinemann F, van Dalen EC, Tushabe DA, Berthold F.

Cochrane Database Syst Rev. 2015 Jan 29;1:CD010685. doi: 10.1002/14651858.CD010685.pub2. Review.

PMID:
25634649
5.
6.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2010 May 12;(5):CD006301. doi: 10.1002/14651858.CD006301.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD006301.

PMID:
20464740

Supplemental Content

Support Center